Arun Upadhyay
CIK 1960039 · View on SEC EDGAR ↗
First SEC filing: Jan. 5, 2023 · Latest: Jan. 5, 2023
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Jan. 3, 2025 | OCGN | F | 41,633 | $0.89 | $37,053 | 306,197 Direct | -11.97% | Disposed | 62.4% (price as of 2026-08-20) |
| Jan. 2, 2025 | OCGN | A | 730,994 | — | — | 730,994 Direct | — | Acquired | (price as of 2026-08-20) |
| Sept. 16, 2024 | OCGN | F | 842 | $1.17 | $985 | 347,830 Direct | -0.24% | Disposed | 23.5% (price as of 2026-08-20) |
| June 17, 2024 | OCGN | F | 917 | $1.42 | $1,302 | 348,672 Direct | -0.26% | Disposed | 1.8% (price as of 2026-08-20) |
| Jan. 3, 2024 | OCGN | F | 41,633 | $0.65 | $27,061 | 349,589 Direct | -10.64% | Disposed | 122.3% (price as of 2026-08-20) |
| Jan. 2, 2024 | OCGN | A | 137,795 | — | — | 137,795 Direct | — | Acquired | (price as of 2026-08-20) |
| Sept. 16, 2023 | OCGN | F | 842 | $0.41 | $345 | 391,222 Direct | -0.21% | Disposed | 252.4% (price as of 2026-08-20) |
| June 16, 2023 | OCGN | F | 917 | $0.51 | $468 | 392,064 Direct | -0.23% | Disposed | 183.3% (price as of 2026-08-20) |
| Jan. 3, 2023 | OCGN | F | 7,102 | $1.25 | $8,878 | 392,981 Direct | -1.78% | Disposed | 15.6% (price as of 2026-08-20) |
| Jan. 3, 2023 | OCGN | A | 379,357 | — | — | 379,357 Direct | — | Acquired | (price as of 2026-08-20) |
| Jan. 3, 2023 | OCGN | A | 315,924 | — | — | 400,083 Direct | +375.39% | Acquired | (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Jan. 2, 2025 | OCGN | Option (Right to Buy) | Common Stock (730,994) | $0.90 | Jan. 2, 2035 | 730,994 | Acquired |
| Jan. 2, 2024 | OCGN | Option (Right to Buy) | Common Stock (137,795) | $0.66 | Jan. 2, 2034 | 137,795 | Acquired |
| Jan. 3, 2023 | OCGN | Option (Right to Buy) | Common Stock (379,357) | $1.25 | Jan. 3, 2033 | 379,357 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 13 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Jan. 5, 2023 | OCGN | Common Stock | 84,159 | Direct |
| Jan. 5, 2023 | OCGN | Option (Right to Buy) [F2]→ Common Stock (1,918) | 1,918 | Direct |
| Jan. 5, 2023 | OCGN | Option (Right to Buy) [F3]→ Common Stock (1,103) | 1,103 | Direct |
| Jan. 5, 2023 | OCGN | Option (Right to Buy) [F4]→ Common Stock (2,397) | 2,397 | Direct |
| Jan. 5, 2023 | OCGN | Option (Right to Buy) [F5]→ Common Stock (4,315) | 4,315 | Direct |
| Jan. 5, 2023 | OCGN | Option (Right to Buy) [F6]→ Common Stock (479) | 479 | Direct |
| Jan. 5, 2023 | OCGN | Option (Right to Buy) [F7]→ Common Stock (10,000) | 10,000 | Direct |
| Jan. 5, 2023 | OCGN | Option (Right to Buy) [F8]→ Common Stock (10,000) | 10,000 | Direct |
| Jan. 5, 2023 | OCGN | Option (Right to Buy) [F9]→ Common Stock (246,000) | 246,000 | Direct |
| Jan. 5, 2023 | OCGN | Option (Right to Buy) [F10,F11,F12]→ Common Stock (31,120) | 31,120 | Direct |
| Jan. 5, 2023 | OCGN | Option (Right to Buy) [F13]→ Common Stock (234,993) | 234,993 | Direct |
| Jan. 5, 2023 | OCGN | Option (Right to Buy) [F14]→ Common Stock (30,000) | 30,000 | Direct |
| Jan. 5, 2023 | OCGN | Option (Right to Buy) [F15]→ Common Stock (33,818) | 33,818 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
OCGN
Ph.D. (6) Chief Scientific Officer| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $480,146 | $209,601 | $877,778 | $554,500 | — | — | $14,004 | $2,136,069 |
| 2024 | $466,200 | $169,720 | $145,738 | $75,501 | — | — | $13,710 | $870,869 |
| 2023 | $466,200 | $126,398 | $394,905 | $391,115 | — | — | $5,458 | $1,384,076 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.